Status:
COMPLETED
Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects
Lead Sponsor:
California Pacific Medical Center Research Institute
Conditions:
Opiate Addiction
Eligibility:
All Genders
21-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of intravenous 6β-Naltrexol administered to opiate dependent subjects
Eligibility Criteria
Inclusion
- Opiate dependent males and females age 21-45 on stable doses of methadone
- Fluent English speaker
- Willing and able to give written consent
Exclusion
- Pregnancy or lactation
- FOR MORE DETAILS CONTACT THE RESEARCH CLINIC.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00829777
Start Date
March 1 2009
End Date
September 1 2009
Last Update
September 16 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CPMC Addiction & Pharmacology Research Laboratory (APRL)
San Francisco, California, United States, 94110